Phone icon(913) 262 1436 emailIconEmail Us

Prebook GSK Flu Vaccines Now

2017-18 GSK Influenza Vaccines

Prebooking is now available for GSK Influenza Vaccines. Pre-booking is available until March 31, 2017. Highlights are listed below. Please contact us for more information

Product Description Contract Price Per Dose Discounted Price Per Dose (2% flu advantage, 2% prompt pay)
FLUARIX QUADRIVALENT (Pre-filled Syringe) $15.91 $15.28
FLULAVAL QUADRIVALENT (Pre-filled Syringe) $15.91 $15.28

FLULAVAL QUADRIVALENT (Multi-Dose Vials)

$14.87 $14.28

 1 Pricing does not include Federal Excise Tax (FET) of $0.75 per dose. Price is per dose, not per 10 pack unit.

Agreement Highlights:

  • Ordering
    • Pre-booking for the 2017-2018 flu season runs through March 31, 2017.
    • Order must be placed via www.gskvaccinesdirect.com or authorized GSK Influenza Vaccine distributors
    • Flu Advantage Discount of 2% available on www.gskvaccinesdirect.com purchases until March 31, 2017.
  • Delivery
    • GSK anticipates shipments of GSK Influenza Vaccines to begin in August 2017. (Subject to Availability)
    • Delivery Schedule: Total prebooked doses to be shipped by September 30, 2017.
    • Delivery Guarantee: Pre-booked orders shipped and invoiced after September 30, 2017 will receive an additional 10% discount.
  • Returns
    • In addition to GSK Influenza Vaccine doses returned in accordance with GSK's returned goods policy as posted on www.gskvaccinesdirect.com, members will be eligible to return up to 30% of their Influenza Vaccine does pre-booked on or prior to March 31, 2017 by June 30, 2018 for full credit regardless of purchase date.

Top

Havrix Vaccine Information

All formulations of Havrix Adult, both pre-filled syringes and vials, are out of stock until May 2017. Twinrix vial and PFS presentations are available for order. To help manage the backorder process, GSK will turn off the ability to order Havrix Adult Prefilled Syringe and Vial presentations.

Top

Rabavert Supply

GSK currently has a limited supply of RabAvert in their distribution centers. Due to delays in the manufacturing process, RabAvert resupply dates have been pushed out from January 2017 to March 2017.

In an effort to manage existing inventory, GSK will continue to accept new orders for RabAvert, however these orders will be placed on backorder until resupply is received. GSK does have a limited supply of RabAvert in inventory and can make product available to physicians who are not able to order through a wholesaler/distributor and who need RabAvert for post-exposure prophylaxis in an emergency situation.

GSK believes that there is sufficient inventory in the W/D channels to meet market demand, however, when GSK has low supply or is out of stock, wholesalers and distributors often allocate available product to their customers due to GSK's backorder.  The wholesalers' and distributors' allocation approach can vary and may be based on customer's historical demand.

Top

LATEST NEWS
SIGN UP NOW
signup
OUR MISSION The Mission of Child Health Advantage is to provide community physicians with easy access to appropriate product portfolios, contract pricing, and robust distribution.